Selective ligands as tools to study histamine receptors

European Journal of Medicinal Chemistry

Volumn 35, Issue 1, 2000, Pages 5-20

  Van Der Goot, Henk ^a   Timmerman, Henk ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

H1 agonists; H1 antagonists; H2 agonists; H2 antagonists; H3 agonists; H3 antagonists; Histamine; Radiolabelled H1 antagonists; Radiolabelled H2 antagonists; Radiolabelled H3 agonists; Radiolabelled H3 antagonists; Tools

Indexed keywords

AMTHAMINE; CIMETIDINE; CLOBENPROPIT; DIMAPRIT; DOXEPIN; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; IMETIT; IMPROMIDINE; MEPYRAMINE; N METHYLHISTAMINE; RANITIDINE; THIAZOLE DERIVATIVE; THIOPERAMIDE; TIOTIDINE;

DRUG RECEPTOR BINDING; HISTAMINE METABOLISM; ISOTOPE LABELING; LIGAND BINDING; RECEPTOR BLOCKING; REVIEW;

EID: 0034010570     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00101-X     Document Type: Review

References (131)

1. Arrang J.M., Garbarg M., Schwartz J.C. Nature (London). 302:1983;832-837.
2. Leurs R., Van der Goot H., Timmerman H. Testa B. Advances in Drug Research. 1991;217-304 Academic Press Ltd., London.
3. Cooper D.G., Young R.C., Durant G.J., Ganellin C.R. Hansch C. Comprehensive Medicinal Chemistry. 1990;323-421 Pergamon Press, Oxford.
4. Ganellin C.R. Ganellin C.R, Parsons M.E. Pharmacology of Histamine Receptors. 1982;10-102 Wright PSG, Bristol.
5. Gerhard G., Schunack W. Arch. Pharm. 313:1980;709-714.
6. Hepp M., Schunack W. Arch. Pharmacol. 313:1980;756-762.
7. Schunack W., et al. Dahlbom R, Nilson J.L.G. Proceedings VIII International Symposium on Medicinal Chemistry. 1985;182-196 Swedish Pharmaceutical Press, Stockholm.
8. Donaldson J., Hill S.J. Br. J. Pharmacol. 87:1986;191-199.
9. Schunack W. Arch. Pharm. 308:1975;75-76.
10. Dzurion P., Schunack W. Eur. J. Med. Chem. 10:1975;129-133.
11. Koper J.G., Van der Vliet A., Van der Goot H., Timmerman H. Pharm. Weekbl. Sci. 12:1990;236-239.
12. Zingel V., Elz S., Schunack W. Eur. J. Med. Chem. 25:1990;673-680.
13. Leschke C., Elz S., Garbarg M., Schunack W. J. Med. Chem. 38:1995;1287-1294.
14. Leurs R., Smit M.J., Tensen C.P., Ter Laak A.M., Timmerman H. Biochem. Biophys. Res. Comm. 201:1994;295-301.
15. Hagelüken A., Grünbaum L., Klinker J.F., Nürnberg B., Harhammer R., Schultz G. Biochem. Pharmacol. 49:1995;901-914.
16. Schlegel D.C., Chakrin L.W. Verderame M. CRC Handbook of Autonomic Drugs and Autacoids. 1986;161-203 CRC Press Inc., Boca Raton.
17. Casy A.F. Rocha e Silva M.R. Handbook of Experimental Pharmacology. 1978;174-214 Springer-Verlag, Berlin.
18. Nauta W.T., Rekker R.F. Rocha e Silva M.R. Handbook of Experimental Pharmacology. 1978;215-249 Springer-Verlag, Berlin.
19. Casy A.F. Uvnäs B. Handbook of Experimental Pharmacology. 1991;549-572 Springer-Verlag, Berlin.
20. Monti J.M. Life Sci. 53:1993;1331-1338.
21. Ison R.R., Franks F.M., Soh K.S. J. Pharm. Pharmacol. 25:1973;887-894.
22. Hill S.J. Pharmacol. Rev. 42:1990;45-83.
23. Hill S.J., Young J.M., Marrian D.H. Nature (London). 270:1977;361-363.
24. Hill S.J., Young J.M. Mol. Pharmacol. 19:1981;379-387.
25. Hill S.J., Young J.M. Br. J. Pharmacol. 68:1980;687-696.
26. Carswell H., Nahorski S.R. Eur. J. Pharmacol. 81:1982;301-307.
27. Kondo M., Taniyama K., Tanaka C. Eur. J. Pharmacol. 114:1985;89-92.
28. Hide M., Fukui H., Watanabe T., Wada H., Yamamoto S. Eur. J. Pharmacol. 148:1988;161-169.
29. Chang R.S.L., Tran V.T., Snyder S.H. J. Pharmacol. Exp. Ther. 209:1979;437-442.
30. Rotter A., Frostholm A. Brain Res. Bull. 16:1986;205-214.
31. Arias-Montaño J.A., Young J.M. Eur. J. Pharmacol. 245:1993;291-295.
32. Hadfield A.J., Robinson N.R., Hill S.J. Biochem. Pharmacol. 32:1983;2449-2451.
33. Leurs R., Bast A., Timmerman H. Biochem. Pharmacol. 38:1989;2175-2180.
34. Fukui H., Mizuguchi H., Liu Y.Q., Leurs R., Kangawa K., Matsuo H., Wada H. Eur. J. Pharmacol. 183:1990;1727-1728.
35. Garbarg M., Traiffort E., Ruat M., Arrang J.M., Schwartz J.C. Schwartz J.C, Haas H. The Histamine Receptor. 1992;73-96 Wiley-Liss, New York.
36. Aceves J., Mariscal S., Morrison K.E., Young M.J. Br. J. Pharmacol. 84:1985;417-424.
37. Tran V.T., Lebovitz R., Toll L., Snyder S.H. Eur. J. Pharmacol. 70:1981;501-509.
38. Taylor J., Richelson E. Eur. J. Pharmacol. 78:1982;279-285.
39. Kanba S., Richelson E. Brain Res. 304:1984;1-7.
40. Hall H., Ögren S.O. Life Sci. 34:1984;597-605.
41. Yanai K., Ryu J.H., Watanabe T., Iwata R., Ido T., Sawai Y., Ito K., Itoh M. Br. J. Pharmacol. 116:1995;1649-1655.
42. Yanai K., Yagi N., Watanabe T., Itoh M., Ishiwata K., Ido T., Masuzawa T. J. Neurochem. 55:1990;409-420.
43. Yanai K., Watanabe T., Hatazawa J., Itoh M., Nunoki K., Hatano K., et al. Neurosci. Lett. 118:1990;41-44.
44. Yanai K., Watanabe T., Yokoyama H., Hatazawa J., Iwata R., Ishiwata K., et al. J. Neurochem. 59:1992;128-136.
45. Korner M., Bouthenet M.L., Ganellin C.R., Garbarg M., Gros C., Ife R.J., Sales N., Schwartz J.C. Eur. J. Pharmacol. 120:1986;151-160.
46. Bouthenet M.L., Ruat M., Sales N., Garbarg M., Schwartz J.C. Neuroscience. 26:1988;553-600.
47. Martinez-Mir M.I., Pollard H., Moreau J., Arrang J.M., Ruat M., Traiffort E., Schwartz J.C., Palacois J.M. Brain Res. 526:1990;322-327.
48. Villemain F.M., Bach J.F., Chatenoud L.M. J. Immunol. 144:1990;1449-1459.
49. Ruat M., Körner M., Garbarg M., Gros C., Schwartz J.C., Tertiuk W., Ganellin C.R. Proc. Natl. Acad. Sci. USA. 85:1988;2743-2747.
50. Van der Goot H., Bast A., Timmerman H. Uvnäs B. Handbook of Experimental Pharmacology. vol. 97:1991;573-748 Springer-Verlag, Berlin.
51. Leurs R., Smit M.J., Timmerman H. Pharmacol. Ther. 66:1995;413-463.
52. Gerhard G., Schunack W. Arch. Pharm. (Weinheim). 314:1981;1040-1045.
53. Parsons M.E., Owen D.A.A., Ganellin R.C., Durant G.J. Agents Actions. 7:1977;31-37.
54. Sterk G.J., Van der Goot H., Timmerman H. Eur. J. Med. Chem. 19:1984;93-94.
55. Blakemore R.C., Ganellin R.C., Leigh B.K., Parsons M.E., Price C.A., Smith I.R., Tertiuk W. Agents Actions. 19:1986;18-25.
56. Impicciatore M., Chiavarini M., Razzetti M., Plazzi P.V. Farmaco (Sci.). 35:1980;418-424.
57. Sterk G.J., Van der Goot H., Timmerman H. Arch. Pharm. (Weinheim). 319:1986;624-630.
58. Sterk G.J., Van der Schaar M.W.G., Rademaker B., Van der Goot H., Timmerman H. Agents Actions. 18:1986;231-234.
59. Leurs R., Timmerman H. Jucker E. Progress in Drug Research. vol. 39:1992;128-165 Birkhäuser Verlag, Basel.
60. Weinstein H., Chou D., Johnson C.L., Kang S., Green J.P. Mol. Pharmacol. 12:1976;738-745.
61. Eriks J.C., Van der Goot H., Timmerman H. Mol. Pharmacol. 44:1993;886-894.
62. Nagy P.I., Durant G.J., Hoss W.P., Smith D.A. J. Am. Chem. Soc. 116:1994;4898-4909.
63. Van der Goot H., Eriks J.C., Leurs R., Timmerman H. Med. Chem. Lett. 4:1994;1913-1916.
64. Eriks J.C., Van der Goot H., Sterk G.J., Timmerman H. J. Med. Chem. 35:1992;3239-3246.
65. Coruzzi G., Timmerman H., Adami M., Bertaccini G. NS Arch. Pharmacol. 348:1993;77-81.
66. Poli E., Pozzoli C., Coruzzi G., Bertaccini G., Timmerman H. Agents Actions. 40:1993;44-49.
67. Coruzzi G., Gambarelli E., Bertaccini G., Timmerman H. NS Arch. Pharmacol. 353:1996;417-422.
68. Buschauer A. Arch. Pharm. (Weinheim). 321:1988;415-418.
69. Ganellin C.R. Creighton A.M, Turner S. The Chemical Regulations of Biological Mechanisms. 1982;1-15 Royal Society of Chemistry, London.
70. McIsaac R.L., Johnston B.J., Flannery M.C. J. Pharmacol. Exp. Ther. 225:1983;186-190.
71. English T.A.M., Gristwood R.W., Owen D.A.A., Wallwork J. Br. J. Pharmacol. 89:1986;335-340.
72. Baumann G., Felix S.B., Heidecke C.D., Riess G., Loher U., Ludwig L., Blömer H. Agents Actions. 15:1984;216-228.
73. Eriks J.C., Van der Goot H., Timmerman H., Dutch Patent Application, 1990, NL 90.00132.
74. Timmerman H., Haaksma E.E.J., Leurs R. Melchiorre C, Gianella M. Recent Advances in Receptor Chemistry. 1988;251-273 Elsevier, Amsterdam.
75. Brimblecombe R.W., Duncan W.A.M., Durant G.J., Emmett J.C., Ganellin C.R., Parsons M.E. J. Int. Med. Res. 3:1975;86-92.
76. Arrang J.M., Schwartz J.C., Schunack W. Eur. J. Pharmacol. 117:1985;109-114.
77. Smit M.J., Leurs R., Alewijnse A.E., Blauw J., Van Nieuw Amerongen G.P., Van de Vrede Y., Roovers E., Timmerman H. Proc. Natl. Acad. Sci. USA. 93:1996;6802-6807.
78. Gilman D.J., Jones D.F., Oldham K., Wardleworth J.M., Yellin T.O. Creighton A.M, Turner S. The Chemical Regulations of Biological Mechanisms. 1982;58-76 Royal Society of Chemistry, London.
79. Streett C.S., Cimprich R.E., Robertson J.L. Scand. J. Gastroenterol. 19:(suppl. 101):1984;109-117.
80. Bradshaw J., Brittain R.T., Clitherow J.W., Daly M.J., Price B.J., Stables R. Br. J. Pharmacol. 66:1979;464P.
81. Krämer I., Schunack W. Arzneim.-Forsch. 36:1986;1011-1014.
82. Brittain R.T., Jack D., Price B.J. Trends Pharmacol. Sci. 2:1981;310-313.
83. Bradshaw J., Butcher M.E., Clitherow J.W., Dowle M.D., Hayes R., Judd D.B., McKinnon J.M., Price B.J. Creighton A.M, Turner S. The Chemical Regulations of Biological Mechanisms. 1982;45-57 Royal Society of Chemistry, London.
84. Donetti A. Actualités de chimie thérapeutique, series 15. 1988;227-246 Société de Chimie Thérapeutique, Châtenay-Malabry.
85. Cavanagh R.L., Usakewicz J.J., Buyniski J.P. J. Pharm. Exp. Pharmacol. 224:1983;171-179.
86. Burkard W.P. Eur. J. Pharmacol. 50:1978;449-450.
87. Smith I.R., Cleverley M.T., Ganellin C.R., Metters K.M. Agents Actions. 10:1980;422-426.
88. Warrender S.E., Norris D.B., Rising T.J., Wood T.P. Life Sci. 33:1983;1119-1126.
89. Gajtkowski G.A., Norris D.B., Rising T.J., Wood T.P. Nature (London). 304:1983;65-67.
90. Rising T.J., Norris D.B. Ganellin C.R, Schwartz J.C. Frontiers in Histamine Research. 1985;61-67 Pergamon, Oxford.
91. Maayani S., Hough L.B., Weinstein H., Green J.P. Costa E, Racagni G. Typical and Atypical Antidepressants: Molecular Mechanisms. 1982;133-147 Raven Press, New York.
92. Foreman J.C., Norris D.B., Rising T.B., Webber S.E. Br. J. Pharmacol. 87:1986;37-44.
93. Hattori Y., Endou M., Gando S., Kanno M. Br. J. Pharmacol. 103:1991;1573-1579.
94. Hattori Y., Gando S., Endou M., Kanno M. Eur. J. Pharmacol. 196:1991;29-36.
95. Batzri S., Harmon J.W. Pharmacology. 32:1986;241-247.
96. Ruat M., Traiffort E., Bouthenet M.L., Schwartz J.C., Hirschfeld J., Buschauer A., Schunack W. Proc. Natl. Acad. Sci. USA. 87:1990;1658-1662.
97. Traiffort E., Pollard H., Moreau J., Ruat M., Schwartz J.C., Matrinez-Mir M.I., Palacios J.M. J. Neurochem. 59:1992;290-299.
98. Van der Werf J.F., Bast A., Bijloo G.J., Van der Vliet A., Timmerman H. Eur. J. Pharmacol. 138:1987;199-206.
99. Arrang J.M., Garbarg M., Schwartz J.C. Neuroscience. 23:1987;149-159.
100. Clapham J., Kilpatrick G.J. Br. J. Pharmacol. 107:1992;919-923.
101. Schlicker E., Betz R., Göthert M.J. NS Arch. Pharmacol. 337:1988;588-590.
102. Schlicker E., Fink K., Hinterthaner M., Göthert M. NS Arch. Pharmacol. 340:1989;633-638.
103. Coruzzi G., Poli E., Bertaccini G. J. Pharmacol. Exp. Ther. 258:1991;325-331.
104. Arrang J.M., Garbarg M., Lancelot J.C., Lecomte J.M., Pollard H., Robba M., Schunack W., Schwartz J.C. Nature (London). 327:1987;117-123.
105. Vollinga R.C., Zuiderveld O.P., Scheerens H., Bast A., Timmerman H. Meth. Find. Exp. Clin. Pharmacol. 14:1992;747-751.
106. Van der Goot H., Schepers M.J.P., Sterk G.J., Timmerman H. Eur. J. Med. Chem. 27:1992;511-517.
107. Garbarg M., Arrang J.M., Rouleau A., Ligneau X., Tuong M.D.T., Schwartz J.C., Ganellin R.C. J. Pharmacol. Exp. Ther. 263:1992;304-310.
108. Howson W., Parsons M.E., Raval P., Swayne G.T.G. Bioorg. Med. Chem. Lett. 2:1992;77-78.
109. Vollinga R.C., De Koning J.P., Jansen F.P., Leurs R., Menge W.M.P.B., Timmerman H. J. Med. Chem. 38:1995;332-333.
110. Vollinga R.C., (1995) Ph. D. Thesis, Free University, Amsterdam, The Netherlands.
111. Coruzzi G., Gambarelli E., Bertaccini G., Timmerman H. NS Arch. Pharmacol. 351:1995;569-575.
112. Arrang J.M., Roy J., Morgat J.L., Schunack W., Schwartz J.C. Eur. J. Pharmacol. 188:1990;219-227.
113. Korte A., Myers J., Shih N.Y., Egan R.W., Clark M.A. Biochem. Biophys. Res. Commun. 168:1990;979-986.
114. West R.E., Zwieg A., Shih N.Y., Siegel M.I., Egan R.W., Clark M.A. Mol. Pharmacol. 38:1990;610-613.
115. Kilpatrick G.J., Michel A.D. Timmerman H, Van der Goot H. New Perspectives in Histamine Research. 1991;69-75 Birkhäuser Verlag, Basel.
116. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H. Agents Actions. 30:1990;13-23.
117. Pollard H., Moreau J., Arrang J.M., Schwartz J.C. Neuroscience. 52:1993;168-189.
118. Leurs R., Tulp M.T.M., Menge W.M.P.B., Adolfs M.J.P., Zuiderveld O.P., Timmerman H. Br. J. Pharmacol. 116:1995;2315-2321.
119. Kathmann M., Schlicker E., Detzner M., Timmerman H. NS Arch. Pharmacol. 348:1993;498-503.
120. Stark H., Purand K., Ligneau X., Rouleau A., Arrang J.M., Garbarg M., Schwartz J.C., Schunack W. J. Med. Chem. 39:1996;1157-1163.
121. Menge W.P.B.M., Van der Goot H., Timmerman H., Eersels J.L.H., Herscheid J.D.M. J. Labelled Comp. Radiopharm. 31:1992;781-786.
122. Leurs R., Kathmann M., Vollinga R.C., Menge W.M.P.B., Schlicker E., Timmerman H. J. Pharmacol. Exp. Ther. 276:1996;1009-1015.
123. Yanai K., HoonRyu J., Watanabe T., Takahashi T., Iwata R., Ido T., et al. Jpn. J. Pharmacol. 61:(suppl.):1993;0-82.
124. Alves-Rodrigues A., Leurs R., Wu T.S., Foged C., Timmerman H. Br. J. Pharmacol. 118:1996;2045-2052.
125. Brown J.D., Oshaughnessy C.T., Kilpatrick G.J., Scopes D.I.C., Beswick P., Clitherow J.W., Barnes J.C. Eur. J. Pharmacol. 311:1996;305-310.
126. Jansen F.P., Wu T.S., Voss H.P., Steinbusch H.W.M., Vollinga R.C., Rademaker B., Bast A., Timmerman H. Br. J. Pharmacol. 113:1994;355-362.
127. Stark H., Purand K., Hüls A., Ligneau X., Garbarg M., Schwartz J.C., Schunack W. J. Med. Chem. 39:1996;1220-1226.
128. Ligneau X., Garbarg M., Vizuette M.L., Diaz J., Purand K., Stark H., Schunack W., Schwartz J.C. J. Pharmacol. Exp. Ther. 271:1994;452-459.
129. Schlicker E., Pertz H., Bitschau H., Purand K., Kathmann M., Elz S., Schunack W. Inflamm. Res. 44:1995;296-300.
130. Schlicker E., Kathmann M., Bitschnau H., Marr I., Redemeister S., Stark H., Schunack W. NS Arch. Pharmacol. 353:1996;482-488.
131. Low C.M.R., Vinter J.G., Kalindjian S.B., Pether M.J. Br. J. Pharmacol. 122:1997;433P.